Epidemiology and Long-Term Outcomes in Cardiac Surgery, Thoracic Transplantation, and Interventional Cardiology

Dear Colleagues,

Cardiac surgery, thoracic transplantation, and interventional cardiology have undergone vast procedural improvements in the past decade. Many new technologies—such as transcatheter valve repair and replacement, next-generation percutaneous coronary interventions, mechanical circulatory support, and extracorporeal organ circulation for transplantation—have now been demonstrated to have safe and efficacious short-term patient outcomes. Furthermore, the refinement of surgical techniques and post-operative management has enabled substantial improvements to be made in procedural success and enhanced recovery. These changes have revolutionized clinical consideration and management for patients with a wide array of circulatory and respiratory diagnoses.

Due to their novelty, it is unknown how these new interventions and techniques are associated with long-term patient outcomes. While many of these newer strategies may provide improved short-term success, further studies assessing the long-term implications of these newer approaches are needed.

This Special Issue welcomes the submission of original research, commentaries, and review articles regarding long-term outcomes in cardiac surgery, thoracic transplantation, and interventional cardiology which may include (but are not limited to) areas such as new surgical techniques, transcatheter interventions, new or expanded uses of current medical devices, predictive modeling, the medical management of post-procedural patients, and analyses of large or administrative databases. We also invite articles discussing methodologic strategies and challenges in designing studies assessing long-term outcomes in cardiac surgery and interventional cardiology.

Dr. Louise Y. Sun
Dr. Matthew William Vanneman
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Cardiovascular Development and Disease is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

• transcatheter
• minimally invasive
• big data
• outcomes
• mechanical circulatory support
• organ preservation
• heart transplantation
• lung transplantation
• percutaneous coronary intervention
• enhanced recovery